Wolters LM - Search Results

1

Contrasting patterns of response to lamivudine monotherapy in chronic hepatitis B patients.

Wolters LM, van Nunen AB, Niesters HG, de Man RA. Wolters LM, et al. Scand J Gastroenterol Suppl. 2000;(232):74-8. Scand J Gastroenterol Suppl. 2000. PMID: 11232497 Clinical Trial.

2

Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.

Wolters LM, Honkoop P, Niesters HG, de Man RA. Wolters LM, et al. J Hepatol. 1998 May;28(5):909-10. doi: 10.1016/s0168-8278(98)80243-2. J Hepatol. 1998. PMID: 9625328 No abstract available.

3

Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?

Wolters LM, Niesters HG, de Man RA, Schalm SW. Wolters LM, et al. Antiviral Res. 1999 May;42(1):71-6. doi: 10.1016/s0166-3542(99)00016-9. Antiviral Res. 1999. PMID: 10333144

4

New nucleoside analogues for chronic hepatitis B.

Schalm SW, Wolters LM, van Nunen AB, Niesters HG, de Man RA. Schalm SW, et al. Among authors: wolters lm. Acta Gastroenterol Belg. 2000 Apr-Jun;63(2):191-3. Acta Gastroenterol Belg. 2000. PMID: 10925461 Review. No abstract available.

5

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

Wolters LM, van Nunen AB, Honkoop P, Vossen AC, Niesters HG, Zondervan PE, de Man RA. Wolters LM, et al. J Viral Hepat. 2000 Nov;7(6):428-34. doi: 10.1046/j.1365-2893.2000.00254.x. J Viral Hepat. 2000. PMID: 11115054 Clinical Trial.

6

Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.

de Man RA, Wolters LM, Nevens F, Chua D, Sherman M, Lai CL, Gadano A, Lee Y, Mazzotta F, Thomas N, DeHertogh D. de Man RA, et al. Among authors: wolters lm. Hepatology. 2001 Sep;34(3):578-82. doi: 10.1053/jhep.2001.26815. Hepatology. 2001. PMID: 11526545 Clinical Trial.

7

Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?

van Nunen AB, Janssen HL, Wolters LM, Niesters HG, de Man RA, Schalm SW. van Nunen AB, et al. Among authors: wolters lm. Antiviral Res. 2001 Nov;52(2):139-46. doi: 10.1016/s0166-3542(01)00178-4. Antiviral Res. 2001. PMID: 11672823 Review.

8

Nucleoside analogues for chronic hepatitis B.

Wolters LM, Niesters HG, de Man RA. Wolters LM, et al. Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1499-506. doi: 10.1097/00042737-200112000-00016. Eur J Gastroenterol Hepatol. 2001. PMID: 11742201 Review.

9

Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

Wolters LM, Hansen BE, Niesters HG, DeHertogh D, de Man RA. Wolters LM, et al. J Hepatol. 2002 Jul;37(1):137-44. doi: 10.1016/s0168-8278(02)00115-0. J Hepatol. 2002. PMID: 12076873

10

The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine.

Wolters LM, Hansen BE, Niesters HG, Levi-Drummer RS, Neumann AU, Schalm SW, de Man RA. Wolters LM, et al. J Hepatol. 2002 Aug;37(2):253-8. doi: 10.1016/s0168-8278(02)00113-7. J Hepatol. 2002. PMID: 12127431 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page